摘要
目的:观察纤溶酶联合依达拉奉治疗短暂脑缺血发作的疗效。方法:将80例短暂脑缺血发作患者随机分为试验组(40例)和对照组(40例),两组均给予拜阿司匹林、阿托伐他汀钙片治疗,治疗组在此基础上给予纤溶酶联合依达拉奉注射液静脉滴注,7d为1个疗程。结果:试验组总有效率明显高于对照组(P<0.05)。结论:纤溶酶联合依达拉奉治疗短暂脑缺血发作疗效显著。
Objective： To observe the efficacy of flbrlnogenase combined with edaravone on transient ischemic attack. Method： 80 cases of transient ischemic attack patients were randomly divided into experimental group（40 cases） and control group（40 cases）. The two groups were both given aspirin, atorvastatin calcium tablets, and experimental group was additionally given fibrinogenase injection combined with edaravone injection for 7 days. Result： The total effective rate of experimental group was significantly higher than that of control group（P〈0.05）. Conclusion： The efficacy of fibrinogenase combined with edaravone on transient ischemic attack is remarkable.
出处
《中国医学创新》
CAS
2012年第27期19-20,共2页
Medical Innovation of China
关键词
纤溶酶
依达拉奉
短暂脑缺血
Fibrinogenase
Edaravone
Transient ischemic attack
